Search - tctmd.com

Displaying 261 - 280 of 1204

Sort: Relevancy | Date

News Daily News

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Shelley Wood

June 22, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Todd Neale

June 15, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Shelley Wood

June 05, 2023

News Daily News

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

L.A. McKeown

June 02, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News ESC Heart Failure 2023

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

Shelley Wood

May 25, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

Presentation Fellows 2023

Introduction

Presenter: Margaret McEntegart

May 11, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News CV Team Pro

Kate Morgan

L.A. McKeown

April 28, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

Advertisement

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

FDA Approves Colchicine for Decreasing CV Events

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

CABG and PCI Comparable in ACS Patients With Left Main CAD

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

With New LDL Goalposts in FH, Combo Therapy Must Start Early

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Introduction

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Kate Morgan

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content